Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Cancer: early-phase trial registry
146 of 430 indexed Lung Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #12 of 28,963 conditions by registered trial count.
430 US clinical trials · 146 currently recruiting · #12 of 28,963 conditions by registered trial count
Lung Cancer: 430 US clinical trials tracked, 146 recruiting.
Lung Cancer is the subject of 430 registered US clinical trials on ClinicalTrials.gov, 146 of them currently open to new participants. 23 are in Phase 3-4 (later-stage) and 181 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 36 of these trials.
Open enrollment, early-phase tilt
Lung Cancer has 430 registered US clinical trials, 146 of them open to new participants right now, about 34% of the total.
- 146
- recruiting participants now
- 34%
- of trials open to enrollment
- 23
- in Phase 3-4 (later-stage)
- 36
- top sponsor: Memorial Sloan Kettering Cancer Center
Corpus placement: #12 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Lung Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Cancer is recruiting below its size-band peers.
146 of 430 indexed trials (34%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Cancer trials is spread across many organizations.
Memorial Sloan Kettering Cancer Center accounts for 36 of 430 trials (8.4%). 179 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Cancer enrolment sits around 89 participants.
Median target enrolment is 89 among the 410 trials that report a genuine target (sentinel values excluded). 212 of those (51.7%) plan for fewer than 100 participants.
-
Lung Cancer research is mostly interventional.
321 interventional and 109 observational studies make up this index (74.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
430 total, page 1 of 9
Integrated Cancer Repository for Cancer Research
University of Nebraska
NCT02012699
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Avera McKennan Hospital & University Health Center
NCT05142033
Molecular and Genetic Analysis of Lung Cancer
Massachusetts General Hospital
NCT03029325
Lung Cancer Biomarkers and Screening
NYU Langone Health
NCT00301119
UNC Pleural Fluid Registry
UNC Lineberger Comprehensive Cancer Center
NCT05620329
Sample Collection for Ongoing Research and Product Evaluation Study
Natera
NCT07318051
Centralized Screening Unit (CSU) at Montefiore-Einstein
Albert Einstein College of Medicine
NCT06284408
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
M.D. Anderson Cancer Center
NCT05049837
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Cancer Institute (NCI)
NCT00001823
Thoracic Specimen Registry
Mayo Clinic
NCT04118660
Detection of Genetic Markers of Lung Cancer
University of Pittsburgh
NCT00280202
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Washington University School of Medicine
NCT07146568
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
NCT05463796
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
NCT00897117
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
NCT06004440
Enhancing Lung Cancer Screening Through Human-Centered Intervention
University of California, Davis
NCT06351085
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Veracyte
NCT06426628
WTC Chest CT Imaging Archive
Icahn School of Medicine at Mount Sinai
NCT03295279
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
Massachusetts General Hospital
NCT05784922
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
University of Texas Southwestern Medical Center
NCT03563976
Cough Capture as a Portal Into the Lung
Albert Einstein College of Medicine
NCT05854563
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
University of California, Irvine
NCT07062172
Collection of Blood From Patients With Cancer
National Cancer Institute (NCI)
NCT00034216
Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
Massachusetts General Hospital
NCT06910956
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Pfizer
NCT07222566
EXoPERT EMERALD Clinical Study
EXoPERT
NCT07186296
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT05995821
Empathic Communication Skills (ECS) Training
Memorial Sloan Kettering Cancer Center
NCT05456841
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Wake Forest University Health Sciences
NCT04577599
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Cancer Institute (NCI)
NCT01441089
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
University of California, San Diego
NCT06577883
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Dana-Farber Cancer Institute
NCT06716580
Lung Cancer Screening in High-risk Black Individuals
Massachusetts General Hospital
NCT05898594
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
University of California, Davis
NCT00899405
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Roswell Park Cancer Institute
NCT06563388
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Cancer Institute (NCI)
NCT00451022
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
University of Maryland, Baltimore
NCT07008664
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
NCT00900419
Health Education Approach to Lung Screening
Virginia Commonwealth University
NCT06070870
Comprehensive Outcomes for After Cancer Health
Pack Health
NCT05349227
A Registry for People With Lung Cancer
Memorial Sloan Kettering Cancer Center
NCT06424327
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
UNC Lineberger Comprehensive Cancer Center
NCT06896162
Collection of Sputum and Labeling for Lung Cancer
bioAffinity Technologies
NCT03457415
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Dana-Farber Cancer Institute
NCT05587439
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Apollomics
NCT03175224
Tribally Engaged Approaches to Lung Screening (TEALS)
University of Oklahoma
NCT04948060
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
SystImmune
NCT05983432
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Bristol-Myers Squibb
NCT06618287
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
NCT05715255
Stereotactic Magnetic Resonance Guided Radiation Therapy
Dana-Farber Cancer Institute
NCT04115254
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 85 |
| Phase 2 | 96 |
| Phase 3 | 22 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Lung Cancer right now
146 recruiting of 430 indexed (34% open).
Phase mix: 23 late (III/IV) vs 181 early (I/II) (early-phase heavy).
Top sponsor: Memorial Sloan Kettering Cancer Center (36 trials), 9 others listed. 50 shown below, recruiting first. #12 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Lung Cancer?
PlainTrial tracks 430 US clinical trials for Lung Cancer, of which 146 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Lung Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.